1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients
Publication
, Conference
Saltos, A; Zheng, H; Arrowood, C; Beasley, G; Ronald, J; El-Haddad, G; Khan, U; Guerra-Guevara, L; Wolf, S; Gu, L; Wang, X; Cantwell, M ...
Published in: Regular and Young Investigator Award Abstracts
November 2022
Duke Scholars
Published In
Regular and Young Investigator Award Abstracts
DOI
Publication Date
November 2022
Publisher
BMJ Publishing Group Ltd
Conference Name
SITC 37th Annual Meeting (SITC 2022) Abstracts
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Saltos, A., Zheng, H., Arrowood, C., Beasley, G., Ronald, J., El-Haddad, G., … Ready, N. (2022). 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2022-sitc2022.1132
Saltos, Andreas, Hong Zheng, Christy Arrowood, Georgia Beasley, James Ronald, Ghassan El-Haddad, Uzma Khan, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/jitc-2022-sitc2022.1132.
Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, et al. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022.
Saltos, Andreas, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2022. Crossref, doi:10.1136/jitc-2022-sitc2022.1132.
Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, Khan U, Guerra-Guevara L, Wolf S, Gu L, Wang X, Cantwell M, Antonia S, Beg A, Ready N. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022.
Published In
Regular and Young Investigator Award Abstracts
DOI
Publication Date
November 2022
Publisher
BMJ Publishing Group Ltd
Conference Name
SITC 37th Annual Meeting (SITC 2022) Abstracts
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology